Response to vaccination against SARS‐CoV‐2 in 168 patients with Waldenström macroglobulinemia: a French Innovative Leukemia Organization (FILO) study

British Journal of Haematology ◽

10.1111/bjh.18055 ◽

2022 ◽

Author(s):

Cécile Tomowiak ◽

Véronique Leblond ◽

Kamel Laribi ◽

Marine Baron ◽

Christian Puppinck ◽

...

Keyword(s):

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Abstract #554 Diagnotic Dilema to Treat or Not? Elevated 25(OH) Vitamin D Secondary to Waldenstrom Macroglobulinemia

Endocrine Practice ◽

10.1016/s1530-891x(20)47231-3 ◽

2018 ◽

Vol 24 ◽

pp. 137

Author(s):

Ronakkumar Patel ◽

Jean Pujals Kury ◽

Ozzie Orbach ◽

Helena Guber

Keyword(s):

Vitamin D ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia ◽

25 Oh Vitamin D

Download Full-text

Monomyelocytic leukemia in an untreated case of Waldenstrom macroglobulinemia

Archives of Internal Medicine ◽

10.1001/archinte.137.4.514 ◽

1977 ◽

Vol 137 (4) ◽

pp. 514-516 ◽

Author(s):

D. Salberg

Keyword(s):

Waldenström Macroglobulinemia ◽

Untreated Case ◽

Waldenstrom Macroglobulinemia

Download Full-text

Waldenstrom macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibody

Archives of Dermatology ◽

10.1001/archderm.128.3.372 ◽

1992 ◽

Vol 128 (3) ◽

pp. 372-376 ◽

Author(s):

M. W. Cobb

Keyword(s):

Basement Membrane ◽

Basement Membrane Zone ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

34 / Acalabrutinib in Patients (pts) With Waldenström Macroglobulinemia (WM) .

10.26226/morressier.5b3b802db1b87b000eceda96 ◽

2018 ◽

Author(s):

Thomas Sheeba ◽

Hannah Woodley

Keyword(s):

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Dasatinib In Waldenström Macroglobulinemia

Case Medical Research ◽

10.31525/ct1-nct04115059 ◽

2019 ◽

Author(s):

Keyword(s):

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of International prognostic scoring system for Waldenstrom macroglobulinemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1159134.626343 ◽

2009 ◽

Author(s):

Massimo Federico ◽

Stefano Luminari

Keyword(s):

Scoring System ◽

International Prognostic Scoring System ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3346961.3035059 ◽

2010 ◽

Author(s):

Xavier Leleu

Keyword(s):

T Cells ◽

Nucleoside Analogue ◽

Cytotoxic T Cells ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4957957.4890058 ◽

2010 ◽

Author(s):

Xavier Leleu

Keyword(s):

Phase Ii ◽

Multicenter Study ◽

Combination Treatment ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969438.793469204 ◽

2013 ◽

Author(s):

Nicolas Mounier ◽

Thomas Cluzeau

Keyword(s):

Randomized Trial ◽

Marginal Zone ◽

Marginal Zone Lymphoma ◽

Lymphoplasmacytic Lymphoma ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718283065.793494613 ◽

2014 ◽

Author(s):

Parameswaran Hari ◽

Binod Dhakal

Keyword(s):

Overall Survival ◽

Somatic Mutations ◽

Clinical Presentation ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text